ENDPOINTS

Kaiser Permanente calls on FDA and Congress to firm up accelerated approval requirements

Kaiser Permanente calls on FDA and Congress to firm up ...

Feb 12, 2025 0

While FDA is implementing new accelerated approval reforms, Kaiser Permanente sa...

Biogen downplays capacity for M&A; Roche’s SMA drug is approved as a tablet

Biogen downplays capacity for M&A; Roche’s SMA drug is ...

Feb 12, 2025 0

Plus, news about Odyssey Therapeutics, GSK, Aligos Therapeutics, Terrain Bioscie...

What CVS is doing about high medical costs

What CVS is doing about high medical costs

Feb 12, 2025 0

CVS Health ended 2024 as it started, with high medical costs in the company’s in...

Pfizer wins approval in new indication for blood cancer drug Adcetris

Pfizer wins approval in new indication for blood cancer...

Feb 12, 2025 0

Pfizer secured an eighth indication for its blood cancer drug Adcetris after the...

AnaptysBio gets a mid-stage win for PD-1 drug in rheumatoid arthritis

AnaptysBio gets a mid-stage win for PD-1 drug in rheuma...

Feb 12, 2025 0

AnaptysBio trumpeted a Phase 2b success in rheumatoid arthritis Wednesday mornin...

AbbVie pens another T cell engager deal, this time with Xilio

AbbVie pens another T cell engager deal, this time with...

Feb 12, 2025 0

AbbVie and Xilio Therapeutics are partnering to make “masked” T cell engagers, w...

Odyssey underwent layoffs; GSK to move vaccine R&D site to Cambridge

Odyssey underwent layoffs; GSK to move vaccine R&D site...

Feb 12, 2025 0

Plus, news about Aligos Therapeutics, Terrain Biosciences, the Gates Foundation ...

Odyssey reportedly underwent layoffs; GSK to move vaccine R&D site to Cambridge

Odyssey reportedly underwent layoffs; GSK to move vacci...

Feb 12, 2025 0

Plus, news about Aligos Therapeutics, Terrain Biosciences, the Gates Foundation ...

Cerula Care raises $3.7M to support cancer patients’ mental health

Cerula Care raises $3.7M to support cancer patients’ me...

Feb 12, 2025 0

Cerula Care has raised $3.7 million in seed funding to help patients better figh...

After passing on M&A offers, Abcuro raises $200M in bid to become commercial drugmaker

After passing on M&A offers, Abcuro raises $200M in bid...

Feb 12, 2025 0

After quickly enrolling its pivotal trial and recruiting more patients with a ra...

Exclusive: Longevity startup targets renegade proteins linked to diabetes and obesity

Exclusive: Longevity startup targets renegade proteins ...

Feb 12, 2025 0

The human genome is chock-full of middle managers. Roughly 2,000 proteins, accou...

Biogen gets $250M in Royalty Pharma deal for lupus program

Biogen gets $250M in Royalty Pharma deal for lupus program

Feb 12, 2025 0

Biogen is turning to Royalty Pharma for some cash in exchange for rights to a lu...

New CMO Dietmar Berger highlights Gilead’s ‘unique situation’ and its HIV ambitions

New CMO Dietmar Berger highlights Gilead’s ‘unique situ...

Feb 12, 2025 0

Dietmar Berger said Gilead is in a “unique situation” as he assumes the role of ...

SpringWorks lands FDA approval for nerve tumor treatment

SpringWorks lands FDA approval for nerve tumor treatment

Feb 12, 2025 0

SpringWorks Therapeutics, a biotech potentially on the verge of being acquired, ...

Travere plans to seek expanded label for kidney drug

Travere plans to seek expanded label for kidney drug

Feb 11, 2025 0

Travere Therapeutics said Tuesday it plans to ask the FDA for approval of its ki...

Biohaven gets FDA priority review for neuro disease drug after refuse-to-file

Biohaven gets FDA priority review for neuro disease dru...

Feb 11, 2025 0

Biohaven's experimental drug troriluzole for the rare, neurodegenerative disease...

39
40
41
42
43

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.